In the media

New Cancer Therapy Brings Hope

Battling blood cancer in my 20s, I put my faith in a clinical trial for a promising new CAR-T treatment.

But does it actually work?

By Hayden Smith, 7 June 2021

‘It was mid-March at Fiona Stanley Hospital in Perth, and a squadron of doctors and nurses had gathered by my bed. Some were methodically […]

2021-06-07T13:00:54+10:00June 7th, 2021|

Cancer survivor Heather Hawkins was devastated by news that early detection of ovarian cancer doesn’t save lives …..

But she has “unshakeable hope” that Cartherics’ innovative treatments promise an alternative path

By Heather Hawkins

24 May 2021

Ovarian Cancer: two words that changed my life forever.

Even today – and it’s been 14 years since diagnosis – they still evoke a very raw and deeply emotional response. It was the first time I’d faced the undeniable fact […]

2021-05-24T14:13:27+10:00May 24th, 2021|

Cartherics Therapies More Essential Than Ever

New research delivers devastating findings about ovarian cancer screening

Four Australian women are diagnosed with ovarian cancer a day and three will eventually die from the disease. It’s usually diagnosed late, because few women show symptoms until they have advanced cancer.

As a junior doctor in London in the mid-1980s, Ian Jacobs saw women undergo chemo and […]

2021-05-20T14:20:54+10:00May 20th, 2021|

Cartherics CEO Alan Trounson remembers Dolly and welcomes Elizabeth Ann

Dolly the cloned sheep is a legend. Not so her technical descendant Elizabeth Ann the endangered black-footed ferret.

By Leigh Dayton

4 March 2021

In 1966 Alan Trounson was enjoying a hike in the hills above Edinburgh, Scotland with his colleague Ian Wilmut when Wilmut revealed a secret. His team at the Roslin Institute had cloned a […]

2021-03-04T11:35:02+11:00March 4th, 2021|

CAR-T Funding is Reaching Staggering New Heights

A survey reveals nearly US$100 market capitalisation

23 February 2021

A survey conducted by Washington DC based BioInformant assesses the growth of the CAR-T arm of immunotherapy research and development. The summary is posted below.

At first the trend was subtle, but the tide has swelled as CAR-T therapies like Kymriah, Yescarta, Tecartus, and […]

2021-04-28T12:42:46+10:00February 23rd, 2021|

Cartherics CEO Alan Trounson on “3-person IVF”

Legislation to be introduced to Australian Parliament

By Leigh Dayton

4 February 2021

Not only is Alan Trounson Cartherics CEO and a leader in embryonic stem cell science, he’s also a pioneer in IVF technology. Back in 1980 the then embryologist made headlines for his participation in the birth of Australia’s first IVF baby, Candice Reed.

Thanks to this […]

2021-02-04T03:41:18+11:00February 4th, 2021|

The Power Of The Pivot – Lessons from the biotech frontline

Back People Not Projects

By Ian Nisbet*

“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch)

In the late 1980s and early 1990s I was working at CSL during the years leading up to its public listing and prior to it becoming the behemoth it […]

2020-11-19T01:14:44+11:00November 19th, 2020|

The Fight Against Cancer Continues ……. Despite COVID-19

18 November 2020

By Leigh Dayton

They may not be able to gather at the Melbourne Convention Centre this year, but global experts in immunotherapy will swap ideas December 15 & 16 as Eradicate Cancer 2020 goes virtual.

Taking on the role of conference convenor for the second time, after the highly successful inaugural Conference in 2018, […]

2020-12-09T09:26:07+11:00November 18th, 2020|

Nobel Chemistry prize going to CRISPR scientists

Genetic scissors: a tool for rewriting the code of life wins the 2020 Nobel Prize for Chemistry

Emmanuelle Charpentier and Jennifer A. Doudna have discovered one of gene technology’s sharpest tools: the CRISPR/Cas9 genetic scissors.

The Royal Swedish Academy of Sciences

7 October 2020

Using these tools, researchers can change the DNA of animals, plants and microorganisms with […]

2020-10-09T23:54:50+11:00October 9th, 2020|

Good news from Cartherics. The company’s off-the-shelf immune therapy for ovarian cancer is close to clinical trials

View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter

Cartherics’ cost-effective ‘off-the-shelf’ ovarian cancer therapy made from special donor umbilical cord blood samples is in the final stages of preclinical development.

By combining immunotherapy and stem cell research, we can manufacture Natural Killer (NK) cells that carry a […]

2020-09-23T05:36:40+10:00September 23rd, 2020|
Go to Top